Literature DB >> 27671209

Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.

Hui Zhao1,2, Chuang Chen2,3, Shen Gu4, Xiaopeng Yan4, Wenjun Jia4, Liang Mao4, Yudong Qiu2,4.   

Abstract

BACKGROUND AND AIM: The superiority of anatomical resection (AR) in patients with hepatocellular carcinoma compared with non-anatomical resection (NAR) remains controversial. We aimed to investigate the prognostic outcomes of AR and NAR for solitary hepatocellular carcinoma (HCC) patients without macroscopic vascular invasion, using a propensity score matching (PSM) analysis.
METHODS: A total of 305 consecutive HCC patients without macroscopic vascular invasion who underwent curative hepatectomy were included in our study. PSM was performed in order to eliminate possible selection bias.
RESULTS: By PSM, the patients were divided into propensity-matched anatomical resection (PS-AR) (n = 114) and propensity-matched non-anatomical resection (PS-NAR) (n = 114) groups. The 1-year, 3-year, and 5-year overall survival rates were 90.4%, 77.7%, and 65.7% in PS-AR and 88.6%, 70.7%, and 52.2% in PS-NAR (P = 0.053), respectively. The 1-year, 3-year, and 5-year recurrence-free survival (RFS) rates were 84.1%, 64.9%, and 45.1% in PS-AR and 75.4%, 48.1%, and 31.0% in PS-NAR (P = 0.005), respectively. Multivariate analysis showed that ICG-R15 (P = 0.022); the Barcelona clinic liver cancer staging (P = 0.044) and microvascular invasion (MVI; P = 0.005) were independent risk factors for the overall survival rate, while type of resection (P = 0.027), surgical margin (P = 0.039), and MVI (P = 0.024) were independent risk factors for the RFS rate. Patients who underwent NAR were prone to early recurrence and marginal recurrence. Subgroup analysis indicated that the RFS rate was significantly better in PS-AR than that in PS-NAR (surgical margin ≥ 1 cm) (P = 0.025). Better RFS rate was observed in PS-AR with MVI compared with PS-NAR (P = 0.016).
CONCLUSIONS: Anatomical resection contributed to improve the RFS rate in solitary HCC patients without macroscopic vascular invasion using PSM analysis, especially in patients with MVI.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  anatomical hepatectomy; hepatocellular carcinoma; microvascular invasion; non-anatomical hepatectomy; propensity score matching analysis

Mesh:

Year:  2017        PMID: 27671209     DOI: 10.1111/jgh.13603

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  23 in total

1.  Successful Anatomic Resection of Tumor-Bearing Portal Territory Delays Long-Term Stage Progression of Hepatocellular Carcinoma.

Authors:  Junichi Shindoh; Yuta Kobayashi; Ryosuke Umino; Kazutaka Kojima; Satoshi Okubo; Masaji Hashimoto
Journal:  Ann Surg Oncol       Date:  2020-07-25       Impact factor: 5.344

2.  Privileged indication of anatomical resection for the hepatocellular carcinoma with microportal invasion?

Authors:  Koo Jeong Kang; Keun Soo Ahn
Journal:  Transl Gastroenterol Hepatol       Date:  2019-01-07

3.  Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.

Authors:  Chuan Li; Xiao-Yun Zhang; Wei Peng; Tian-Fu Wen; Lu-Nan Yan; Bo Li; Jia-Yin Yang; Wen-Tao Wang; Ming-Qing Xu
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

4.  Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status.

Authors:  Lu-Nan Qi; Liang Ma; Yuan-Yuan Chen; Zu-Shun Chen; Jian-Hong Zhong; Wen-Feng Gong; Yan Lu; Bang-De Xiang; Le-Qun Li
Journal:  Ann Med       Date:  2020-01-20       Impact factor: 4.709

Review 5.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

6.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

Review 7.  What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?

Authors:  Naoya Sato; Shigeru Marubashi
Journal:  Surg Today       Date:  2021-08-14       Impact factor: 2.549

8.  Short-term efficacy of precise hepatectomy and traditional hepatectomy for primary liver cancer: a systematic review and meta-analysis.

Authors:  Xu Niu; Jing Liu; Zhangdong Feng; Teng Zhang; Tuo Su; Wei Han
Journal:  J Gastrointest Oncol       Date:  2021-12

9.  Preoperative Prediction of Microvascular Invasion Risk Grades in Hepatocellular Carcinoma Based on Tumor and Peritumor Dual-Region Radiomics Signatures.

Authors:  Fang Hu; Yuhan Zhang; Man Li; Chen Liu; Handan Zhang; Xiaoming Li; Sanyuan Liu; Xiaofei Hu; Jian Wang
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

10.  Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Multi-Parametric MRI Radiomics.

Authors:  Yang Zhang; Zhenyu Shu; Qin Ye; Junfa Chen; Jianguo Zhong; Hongyang Jiang; Cuiyun Wu; Taihen Yu; Peipei Pang; Tianshi Ma; Chunmiao Lin
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.